Selvita demonstrates strong revenue growth in H1 2017

Krakow, Poland – September 15, 2017 – Selvita, one of the largest drug discovery companies in Europe, has published semiannual financial results. In H1 2017 Selvita Group recognized total operating revenues (incl. grants) of PLN 59.7 MM, which means a 109% increase compared to H1 2016 when the operating revenues…

More

Selvita exhibits at ChemOutsourcing

Krakow, 28 August 2017 – Selvita will participate and exhibit at the upcoming Pharma ChemOutsourcing 2017 conference, which will take place 18 – 20 September 2017, in Ocean Place Resort, Long Branch, NJ. ChemOutsourcing is the largest USA-based API show attracting annually 700-800 chemists and business development personnel from the pharmaceutical,…

More

Selvita will exhibit at 19th RSC/SCI Medicinal Chemistry Symposium

Kraków, Poland – 24 August 2017 – Selvita will participate in and exhibit at the upcoming 19th RSC/SCI Medicinal Chemistry Symposium which will take place on 10 – 13 September 2017, in Cambridge, UK. Reflecting current trends in medicinal chemistry and pharmaceutical research, the scientific programme of the conference will feature…

More

Selvita presents at 18th Drug Discovery Summit in Berlin

Krakow, Poland – 06 June 2017 – Selvita is a proud sponsor of the upcoming 18th Drug Discovery Summit which will take place on June 12 – 13, 2017, in Berlin, Germany. This event will gather over 250 delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions,…

More

12345...10...